LAUREN REMEGI: Open Payments
NPI 1356957930 · BEAUFORT, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$683 in 8 payments from 7 companies in 2025. Trend: 2023 $874 · 2024 $806 · 2025 $683
Food & beverage: $583Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 2 | $119 |
| Amgen Inc. | 1 | $116 |
| GENZYME CORPORATION | 1 | $114 |
| ABBVIE INC. | 1 | $112 |
| Regeneron Healthcare Solutions, Inc. | 1 | $109 |
| Organon LLC | 1 | $70 |
| Arcutis Biotherapeutics, Inc. | 1 | $45 |
Products named: DUPIXENT, TREMFYA, OTEZLA, SKYRIZI, VTAMA, Zoryve.
Industry payments across SC — which companies pay providers there.
